AMPHENOL CORP /DE/ entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $350,000,000 (effective 2023-03-16).
“The Notes were issued pursuant to an indenture dated as of March 16, 2023 (the “Indenture”) between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and certain of the terms of the Notes were established pursuant to an Officers’ Certificate dated March 30, 2023 (the “Officers’ Certificate”) in accordance with the Indenture.”
Material Agreements
AMPHENOL CORP /DE/ entered into underwriting agreement with BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several Underwriters named in Schedule A thereto valued at $350,000,000 (effective 2023-03-27).
“The Notes were sold in an underwritten public offering pursuant to an underwriting agreement, dated March 27, 2023, by and between the Company and BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the several Underwriters named in Schedule A thereto.”
Material Agreements
AMPHENOL CORP /DE/ entered into Underwriting Agreement with BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC valued at $350,000,000 (effective 2023-03-27).
“On March 27, 2023, Amphenol Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and between the Company and BNP Paribas Securities Corp., BofA Securities, Inc. and J.P. Morgan Securities LLC , as representatives of the several Underwriters named in Schedule A thereto, relating to the offer and sale of $350,000,000 aggregate principal amount of the Company’s 4.750% Senior Notes due 2026 (the “Notes”).”
Earnings Releases
AMPHENOL CORP /DE/ reported Full Year 2022 results: revenue $12.623 billion, EPS Record GAAP Diluted EPS of $3.06. Guidance initiated.
“Full Year 2022 Highlights: • Record sales of $12.623 billion, up 16% in U.S. dollars and 15% organically compared to the full year 2021 • Record GAAP Diluted EPS of $3.06, up 22% compared to prior year • Record Adjusted Diluted EPS of $3.00, up 21% compared to prior year”
“Fourth Quarter 2022 Highlights: • Sales of $3.239 billion, up 7% in U.S. dollars and 8% organically compared to the fourth quarter of 2021 • GAAP Diluted EPS of $0.82, up 14% compared to prior year • Adjusted Diluted EPS of $0.78, up 11% compared to prior year”
Prahlad Singh was appointed as member of the Board at AMPHENOL CORP /DE/.
“Also, on January 12, 2023, to fill the resulting vacancy, the Board appointed Prahlad Singh as a member of the Board effective immediately.”
Nancy Altobello was appointed as Director at AMPHENOL CORP /DE/.
“Also, on July 27, 2021, to fill the resulting vacancy, the Board of Directors of the Company appointed Nancy Altobello, 63, as a member of the Company’s Board of Directors effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.